PCSK9 and familial hypercholesterolemia: On the other hand, gain-of-function mutations of PCSK9 result in familial hypercholesterolemia and increased cardiovascular risk, while loss-of-function mutations are associated with better lipid profile and confer to lower cardiovascular risk.44